1221411-72-8

Basic information

• Product Name: sp-420
• Synonyms: 4-Thiazolecarboxylic acid, 4,5-dihydro-2-[2-hydroxy-4-[2-(2-methoxyethoxy)ethoxy]phenyl]-4-methyl-, ethyl ester, (4S)-
• CAS NO: 1221411-72-8
• Molecular Formula: C₁₈H₂₅NO₆S
• Molecular Weight: 383.4592
• Mol File: 1221411-72-8.mol
• Article Data: 2

Chemical Properties

• Melting Point: 68-70 °C(Solv: ethyl acetate (141-78-6); hexane (110-54-3))
• Boiling Point: 520.5±60.0 °C(Predicted)
• Appearance: /
• Density: 1.24±0.1 g/cm3(Predicted)
• PKA: 8.78±0.40(Predicted)
• CAS DataBase Reference: sp-420(CAS DataBase Reference)
• NIST Chemistry Reference: sp-420(1221411-72-8)
• EPA Substance Registry System: sp-420(1221411-72-8)

Safety Data

• Hazardous Substances Data: 1221411-72-8(Hazardous Substances Data)

Usage

General Description

SP-420 is a blend of highly effective surfactants and micro-emulsifiers designed for use in oilfield stimulation and fracturing applications. This chemical mixture is specifically formulated to improve the efficiency of hydraulic fracturing operations by reducing the surface tension of water and increasing its ability to carry proppants and other treatment chemicals. SP-420 can also enhance the performance of other additives in the fracturing fluid, leading to improved well productivity and increased oil and gas recovery rates. Additionally, this chemical blend is environmentally friendly and biodegradable, making it a preferred choice for use in hydraulic fracturing operations.

Upstream product

• 847829-15-6 ethyl (S)-2-(2,4-dihydroxyphenyl)-4,5-dihydro-4-methyl-4-thiazolecarboxylate 
• 50586-80-6 toluene-4-sulfonic acid 2-(2-methoxyethoxy)ethyl ester 

Downstream Products

• 911714-45-9 (S)-4,5-dihydro-2-(2-hydroxy-4-(3,6-dioxaheptyloxy)phenyl)-4-methyl-4-thiazolecarboxylic acid 
• 1221411-75-1 isopropyl (S)-4,5-dihydro-2-(2-hydroxy-4-(3,6-dioxaheptyloxy)phenyl)-4-methyl-4-thiazolecarboxylate 

Relevant articles and documents

DESFERRITHIOCIN POLYETHER ANALOGUES AND USES THEREOF

Desferrithiocin analogues represented by the structural formulae described here, such as formula (I), are useful in treating conditions such as metal overload (e.g., iron overload from transfusion therapy), oxidative stress, and neoplastic and preneoplast